Lightnews — Scholar-powered news

MattBloodMD

@doctorblood.bsky.social

230 followers 610 following 2 posts

Hematology/Internal Medicine Clinician, Researcher, Educator. Thrombosis Medicine, Safe AI, Privacy, Politics and Art.

Posts Media Videos Starter Packs

Reposted by MattBloodMD

Saskia Middeldorp @middeldorps.bsky.social · Dec 10

Extended-dose DOAC vs full-dose DOAC #Renove trial #ASH24 Late breaking abstract. Officially, reduced dose was not non-inferior, but recurrent #VTE rates were low and there is a substantial reduction in major and non-major bleeding. Congratulations to the French colleagues of #Innovte!

2 16

Reposted by MattBloodMD

MattBloodMD @doctorblood.bsky.social · Nov 29

We humbly thank the reviewers for their suggestions. We would like to resubmit this improved manuscript for your consideration. #AcademicSky #MedSky

9 21 130

MattBloodMD @doctorblood.bsky.social · Nov 29

No Apparent Association Between mRNA vaccines and venous thromboembolism
www.sciencedirect.com/science/arti...

No apparent association between mRNA COVID-19 vaccination and venous thromboembolism

By January 2022 over ten billion doses of COVID-19 vaccines had been administered worldwide. Concerns about COVID-19 vaccine-associated thrombosis aro…

www.sciencedirect.com

1 6

MattBloodMD @doctorblood.bsky.social · Nov 29

We humbly thank the reviewers for their suggestions. We would like to resubmit this improved manuscript for your consideration. #AcademicSky #MedSky

9 21 130

Reposted by MattBloodMD

Nicolas Gendron @gendronn.bsky.social · Nov 27

🎉Congratulations Francis and the 🇫🇷 INNOVTE team for the RENOVE study that will be presented at ASH 2024 @ash-hematology.bsky.social as a Late-Breaking Abstract !
💊Reduced- Vs Full dose of DOAC for long terme anticoagulation after VTE ⤵️
ash.confex.com/ash/2024/web...

Paper: Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence

ash.confex.com

3 9